1. Home
  2. SMJF vs BMEA Comparison

SMJF vs BMEA Comparison

Compare SMJF & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SMJF

SMJ International Holdings Inc. Class A Ordinary Shares

N/A

Current Price

$5.19

Market Cap

88.7M

Sector

N/A

ML Signal

N/A

Logo Biomea Fusion Inc.

BMEA

Biomea Fusion Inc.

HOLD

Current Price

$1.25

Market Cap

85.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMJF
BMEA
Founded
1988
2017
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.7M
85.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SMJF
BMEA
Price
$5.19
$1.25
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$9.83
AVG Volume (30 Days)
692.9K
902.6K
Earning Date
09-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.19
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$68.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$0.87
52 Week High
$5.70
$2.99

Technical Indicators

Market Signals
Indicator
SMJF
BMEA
Relative Strength Index (RSI) 65.04 45.88
Support Level $4.86 $1.23
Resistance Level $5.61 $1.46
Average True Range (ATR) 0.18 0.09
MACD -0.06 0.01
Stochastic Oscillator 53.85 38.16

Price Performance

Historical Comparison
SMJF
BMEA

About SMJF SMJ International Holdings Inc. Class A Ordinary Shares

SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, broadloom carpets and vinyl tiles. The company operates under the proprietary brand 'SMJ'.The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. It has presence in several countries including Malaysia, Indonesia, Philippines, Hong Kong, PRC, Taiwan, Korea, Thailand, Vietnam, Brunei, and India. It generates revenue mainly through the sale and distribution of its flooring products prominently in Singapore.

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

Share on Social Networks: